Erratum to: J Mol Neurosci

DOI 10.1007/s12031-016-0717-8

The original version of this article unfortunately contained mistakes in Table 1. We apologize to all readers and make the following corrections:

  1. 1.

    In Table 1 continued, under Outcome column, sixth row, the statement “Prevent cerebral blood w reduction” should be changed to “Prevent cerebral blood flow reduction”.

  2. 2.

    In Table 1 continued, under Outcome column, seventh row, the statement “Raf inhibitor SB386023-b” should be changed to “Prevent reduction in regional CBF and neurological scores”.

  3. 3.

    In Table 1 continued, under Outcome column, eighth row, the statement “Raf inhibitor SB386023-b” should be changed to “Prevent the reduction of cerebral blood flow”.